Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details
Media – Mode Shifting Dos, Don’ts and Benefits
Media – Mode Shifting Dos, Don’ts and Benefits
Mode Shifting Dos, Don’ts and Benefits
Gary Hutchinson
By Gail Dutton
World Trade WT-100
February 1, 2013
Stay on top of the industry trends
You may also like
Incyte announces FDA approval for Zynyz™
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read Details
Amicus Therapeutics announces EC approval for Pombiliti™
Congratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details